Our aim was to quantify irradiation-induced permeability alterations of the blood-bone marrow barrier (BMB) with dynamic contrast enhanced magnetic resonance imaging (MRI). The standard small molecular contrast agent, gadoterate meglumine, and a new macromolecular contrast agent, carboxymethyldextran-Gd-DOTA (CMD-Gd-DOTA), were compared. Twenty New Zealand white rabbits underwent MRI of the bone marrow before and 1-2 days after total body irradiation (TBI). Dynamic, repetitive T1-weighted MRI was performed before and after injection of either 0.05 mmol/kg BW CMD-Gd-DOTA (n = 10) or 0.5 mmol/kg BW gadoterate (n = 10). Bone marrow contrast enhancement was quantified as delta signal intensity: ⌬SI = ͉(SI post − SI pre ) / SI pre ͉ * 100%. All MRI data were compared with the histopathologic BMB ultrastructure. Dynamic bone marrow ⌬SI data steadily increased after CMD-Gd-DOTA injection, while blood ⌬SI data slightly decreased. This bone marrow contrast enhancement, indicative of contrast agent extravasation, was significantly higher and prolonged in the irradiated group as compared to non-irradiated controls (P Ͻ 0.05) and corresponded to irradiation-induced alterations of the BMB ultrastructure seen on electron microscopy. By contrast, ⌬SI data of non-irradiated and irradiated marrow were not significantly different following gadoterate injection (P Ͼ 0.05). We conclude that irradiation-induced alterations in BMB permeability could be reliably assessed with dynamic MRI, using the new macromolecular contrast agent CMD-Gd-DOTA. Bone Marrow Transplantation (2000) 25, 71-78.
The role of total body irradiation (TBI) as a conditioning regimen for bone marrow transplantation is not yet fully understood. Originally, TBI was administered to induce myeloablation along with elimination of a residual malignant cell population and to induce immunologic suppression. 1 However, this could be also achieved with highdose conditioning chemotherapy. Recent investigations demonstrated that TBI may not only cause changes in bone marrow cell composition but also changes in bone marrow stroma, which may be essential for a successful engraftment. 2 Intravenously injected donor blood stem cells enter the hematopoietic compartment through specialized vascular marrow sinuses whose walls consist of a complete endothelial layer and an incomplete adventitial layer. 3 This so called blood-bone marrow barrier (BMB) is an anatomical barrier that exerts functional control over the magnitude of cell traffic between the extravascular and intravascular marrow compartment. [3] [4] [5] If the infused stem cells are able to traverse the BMB and enter the hematopoietic compartment, successful engraftment can be achieved. 2 Due to pretransplant irradiation, histological alterations of the BMB ultrastructure were found and assumed to be essential for disruption of the endothelial barrier and to permit large-scale entry of transplanted cells into the hemopoietic compartment. 2 In mice, the abolition of the BMB occurred within 24 h after irradiation, persisted for about a week and the barrier function was restored after 2 weeks. 2 However, the exact time of onset and end of increased BMB permeability may be different in other species and in addition, may vary interindividually. Furthermore, the extent of increased BMB permeability remains unknown and, up to now, there has been no reliable method for quantifying BMB permeability in vivo.
Magnetic resonance imaging (MRI) offers optimal visualization of the normal and pathologic bone marrow due to excellent tissue contrast and multiplanar tomography. 1, [6] [7] [8] [9] [10] [11] [12] Bone marrow MR signal changes following bone marrow transplantation are well described and correlate with histological changes in bone marrow cell composition. 1, 9 However, less attention has been paid to the development of a diagnostic method for the quantification of BMB permeability. For this task a tracer is needed, which is confined to the vascular space in normal conditions and which would only extravasate through capillary walls with an abnormally high permeability. New macromolecular contrast media (MMCM) for MRI may be suited for this task because their distribution is comparable to the blood volume in healthy tissues and because they show an abnormal transendothelial leakiness in various pathological conditions, including inflammation, ischemia and malignancies. [13] [14] [15] [16] In addition, MMCM-enhanced MRI could be used to quantify irradiation-induced increases in tumor capillary permeabilities. 17, 18 A new approach to evaluating the BMB with MRI is to quantify the permeability of these macromolecules across the endothelium of bone marrow microvessels.
The goal of this study was to quantify changes in BMB permeability resulting from TBI using contrast enhanced MRI and to correlate the quantitative data with histopathology. The specificity for BMB characterization was compared using the standard small molecular contrast agent, gadoterate meglumine (Gd-DOTA) and a recently developed macromolecular contrast agent, carboxymethyldextran (CMD)-Gd-DOTA. Our hypothesis was that permeability changes of the blood-bone marrow barrier due to TBI can be quantified with CMD-Gd-DOTA but not with Gd-DOTA.
Materials and methods

Animals
The study was performed according to the guidelines of the National Institutes of Health and the recommendations of the Committee on animal research, University of Münster, Germany.
Twenty 6-week-old female New Zealand white rabbits underwent MRI of the lumbar and sacral bone marrow before and 1-2 days after total body irradiation (TBI). For TBI, anesthesia of the animals was not required, since they were immobilized in a relatively small box. For MRI, the animals were anesthetized by an intramuscular injection of 75 mg/kg body weight (BW) Ketanest (10% = 100 mg/ml) and 10 mg/kg BW Rompum (2% = 20 mg/ml). A 23G butterfly cannula (Abbott Laboratory, North Chicago, IL, USA) was inserted into an ear vein for contrast medium injection. During MRI, 10 rabbits received a bolus injection of 0.05 mmol/kg CMD-Gd-DOTA. The other 10 animals received 0.1 mmol/kg Gd-DOTA. After completion of all imaging procedures, the animals were sacrificed by intracardiac injection of 3 ml T61 (0.2 g embutramide, 0.05 g mebezoniumjodid, 0.005 g tetracainhydrochloride per ml) and tissue samples were removed for histopathological analysis. In addition, tissue samples from three nonirradiated control rabbits were analyzed histopathologically.
Total body irradiation
Each rabbit received 12 Gy TBI, administered as 4 Gy fractions on 3 consecutive days, corresponding to the TBI conditioning regimen in humans. The rabbits were individually positioned prone in a plastic box and irradiated with gamma photons using a cobalt 60 source (Philips Medical Systems, Best, The Netherlands) at a dose rate of 0.13 Gy/min, with an opposed field technique. Before and 1-2 days after irradiation, all animals underwent MRI.
Contrast media
Gd-DOTA is one of the standard contrast agents for routine MR examinations. This extracellular contrast agent is characterized by a small molecular weight of 0.5 kDa and a distribution volume (0.266 l/kg), which is equal to that of extracellular water. 19 The gadolinium complex enhances blood and tissue signal intensities on T1-weighted MR images by shortening spin lattice relaxivities (R1), quantified as R1 = 2.9 mm
. The signal intensity on T2-weighted images is not significantly affected by this contrast agent, therefore the spin-spin relaxivity R2 = × mm −1 s −1 is small (37°C and 20 MHz). 19 To date, Gd-DOTA has been clinically administered to more than two million patients with good local and systemic tolerance as well as low toxicity. Plasma half-life in rabbits is approximately 12 min with fast elimination mainly through the urine.
Carboxymethyldextran (CMD)-GD-DOTA is a new, paramagnetic, macrocyclic, macromolecular polymer with a mean molecular weight of 52 kDa, which is about 100 times larger than Gd-DOTA. The distribution volume (0.13 l/kg) corresponds to the blood volume. CMD-Gd-DOTA is produced by Guerbet (Paris, France) as described in detail by Corot et al, 20 with a concentration of 0.1 m gadolinium (Gd)/l and a viscosity 8.5 mPa*s . The spin lattice relaxivity R1 = 10.6 mm −1 s −1 is more than twice that of Gd-DOTA. Therefore, a low dose of 0.05 mmol/kg body weight is sufficient for intravenous bolus injection. The spin-spin relaxivity R2 is 11.1 mm −1 s −1 in rabbit plasma at 37°C and 20 MHz. 19 Previous safety evaluations demonstrated no acute toxicity up to a maximum dose of 5 mmol Gd/kg body weight and the biocompatibility tested in vitro was comparable to that of Gd-DOTA. 20 
Magnetic resonance imaging
MR imaging was performed using a 1.5 Tesla scanner (Magnetom Vision, Siemens, Erlangen, Germany). The rabbits were placed supine in a standard circular polarized phased array coil with an inner diameter of approximately 18 × 30 cm. An external standard phantom filled with corn oil (15 mm inner diameter tube) was included in the field of view. Precontrast pulse sequences comprised multislice T1-weighted Spinecho (SE) 600/15 (TR/TE) and T2-weighted Turbo-SE (TSE) 4000/96 (TR/TE) images. All pre-contrast images were obtained in an axial orientation with a field-of-view of 150 × 120 mm, a 384 (phase) × 512 (frequency) matrix and an effective slice thickness of 4 mm. For dynamic imaging, a representative slice through the sacral bone marrow was chosen and saturation pulses were placed above and below this slice to eliminate any inflow effects. Immediately before and after contrast medium injection, a repetitive dynamic 2D-fast low angle shot (FLASH) 60°/50/4 (␣/TR/TE) sequence was obtained with a 200 mm 2 field-of-view, a 256 2 matrix and a slice thickness of 4 mm. For dynamic scanning, three precontrast and 60 post-contrast images were acquired within 1 h. During the first 20 min post contrast, images were obtained every 30 s and during the following 40 min images were obtained every 2 min. After completion of the dynamic scans, ie 60 min p.i., additional delayed SE 600/15 and TSE 4600/96 images were obtained using the same imaging parameters as for the pre-contrast images.
Tissue analysis
Bone marrow specimens of the lumbar spine, sacrum and femur of all 20 irradiated rabbits as well as three additional, non-irradiated control rabbits were obtained for histological analysis. All bone samples were decalcified. For standard histopathological analyses, bone marrow slices were fixed in 10% formalin solution, paraffin slabs were cut corresponding to the orientation of MR sections and all samples were stained with hematoxylin and eosin (H&E). To determine the integrity of the endothelial layer of the BMB, bone slices were fixed in glutaraldehyde, and the integrity of the sinus endothelium was evaluated with electron microscopy.
Data analysis
Average signal intensities (SI) of the bone marrow and blood within the inferior vena cava or iliac veins were measured from two to three representative operator defined regions of interest (ROI). The average signal intensity data were corrected for slight spectrometer variation over time by dividing by the signal intensity from the oil phantom in the field of view.
For evaluation of static T1-and T2-weighted images, changes in signal intensity before (SIpre) and following (SIpost) contrast medium injection were calculated as:
Statistics
Quantitative enhancement data are presented as means and standard errors. Comparisons of pre-and post-irradiation MRI data, as well as comparisons between the two contrast agents, were determined with a paired t-test. Statistical significance was assigned if P Ͻ 0.05.
Results
Histopathology
Prior to irradiation, histopathological analysis of sacral, lumbar and femoral tissue showed normal bone marrow with hematopoietic cells at all stages of hematopoiesis and a few fat cells (Figure 1a) . Following irradiation, bone marrow H&E stains demonstrated a substantial decrease of hematopoietic cells as compared to non-irradiated controls. Erythropoietic, lymphopoietic and thrombopoietic cells were substantially reduced (Figure 1b) .
Electron microscopy of normal, non-irradiated bone marrow samples showed normal endothelial cells with elongated or triangular nuclei with heterochromatin ( Figure 2a Representative H&E stains (×80 magnification) of the sacral bone marrow before (a) and after (b) 12 Gy total body irradiation. In (a), the non-irradiated hematopoietic marrow is highly cellular and shows only a few fat vacuoles. In (b), the irradiated bone marrow demonstrates a substantial loss of all cell lines of hematopoiesis.
the inner surface of the vessels. The intact sinus wall demonstrated a continuous endothelial layer at the luminal surface (Figure 2b ). The adventitial layer at the abluminal surface was often replaced by macrophages or hematopoietic cells.
After irradiation, the sinusoids showed severe damage with swelling of the endothelial cells, both in the peri- Figure 2 Electron microscopy of representative bone marrow sinusoids before irradiation (a and b; ×4000 magnification) and after irradiation (c and d; ×4000 magnification). In (a) a normal, non-irradiated endothelial cell is shown with an normal, elongated nucleus (arrow). In (b) a normal sinusoid wall is shown with an intact, continuous endothelium (arrowheads). In (c) an irradiated endothelial cell with dilated perinuclear space and swollen cytoplasm is shown (arrows), reflecting increased permissiveness of the endothelial barrier. In (d), the irradiated sinus is dilated and the sinusoidal lining is damaged with interendothelial discontinuities (arrowheads). nuclear region and cytoplasmic processes (Figure 2c ). The cytoplasm lost its density and became lighter. The sinus endothelium and hematopoietic cells showed sloughing of the plasma membranes, which formed numerous loops. The endothelium lost its continuity (Figure 2d ). Macrophages were frequently seen within the sinus lumen.
Bone marrow imaging
Pre-contrast images: Qualitative changes in bone marrow morphology due to the irradiation procedure could be already depicted with non-enhanced T2-weighted MR images. Following irradiation, sacral and lumbar bone marrow signal intensity increased on T2-weighted sequences, histologically corresponding to post-irradiation edema and a decline in bone marrow cells (Figure 1 ). However, these signal intensity changes following irradiation were not statistically significant (P Ͼ 0.05, data not shown).
Contrast enhanced dynamic data:
Following injection of the standard small molecular MR contrast agent gadoterate meglumine, central venous blood and bone marrow demonstrated a strong and brief signal enhancement (Figure 3a, b) . Dynamic ⌬SI data of blood and bone marrow demonstrated peak values at 2-3 min p.i., followed by a rapid, triexponential decay (Figure 3c ). The dynamic enhancement pattern, in both normal and irradiated bone marrow, rose to a peak value early in the experiment, then decreased, and paralleled the blood curve by 2 min after injection (Figure 3a-c) . Although the mean peak ⌬SI data of the irradiated bone marrow appeared to be higher compared to the mean peak ⌬SI data of the non-irradiated bone marrow, these differences were not significant due to overlapping standard deviations (Figure 3c ; P Ͼ 0.05).
Following injection of CMD-Gd-DOTA, a nearly constant blood pool enhancement was observed (Figure 4a, b) with a slow, monoexponential decay of the dynamic blood ⌬SI curve (Figure 4c) . Normal, non-irradiated bone marrow demonstrated only minor signal enhancement after injection of the macromolecular contrast agent (Figure 4a ) with parallel ⌬SI data compared to the blood curve (Figure 4c ). After irradiation, however, the bone marrow demonstrated a strong enhancement (Figure 4b ). Mean ⌬SI data of the irradiated bone marrow steadily increased for up to 10-15 min post contrast, while blood enhancement data slowly decreased (Figure 4c ). This tissue-blood relationship is indicative of endothelial permeation and extravasation of the injected contrast agent into the bone marrow interstitium and is due to the discontinuous bone marrow sinus endothelium demonstrated by electron microscopy (Figure Since mean blood ⌬SI data did not change significantly before or after irradiation, only the pre-irradiation dynamic blood curve is displayed. Differences between Gd-DOTA enhancement of the non-irradiated and irradiated bone marrow were not significant (P Ͼ 0.05).
2). Hence, significantly greater average peak ⌬SI data were seen in the irradiated bone marrow as compared to the nonirradiated bone marrow using the macromolecular contrast medium CMD-Gd-DOTA (P Ͻ 0.05; Figure 4c ).
Delayed post-contrast images:
One hour following injection of gadoterate, blood signal intensity was back to baseline. Signal intensities of the bone marrow demonstrated a minor persistent enhancement, but ⌬SI data for nonirradiated and irradiated bone marrow were not significantly different (Figure 5a ; P Ͻ 0.05). Corresponding to the known low blood half-life of about 20 min, most of the low molecular contrast agent had already been excreted by the kidneys. One hour following injection of CMD-Gd-DOTA, cen-
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tral venous blood still showed about 70% enhancement, corresponding to a known blood half-life of about 2 h of this blood pool agent. Accordingly, the bone marrow also demonstrated a significant, persistent enhancement and quantitative ⌬SI data were significantly higher in irradiated as compared to non-irradiated sacral bone marrow on late post-contrast MR images (Figure 5b ; P Ͻ 0.05).
Discussion
Using macromolecular contrast media, irradiation-induced alterations of the bone marrow sinus endothelium could be quantified non-invasively by MR imaging. Our experimental data demonstrate that TBI increases the sinus Bone marrow, however, demonstrated significantly higher ⌬SI data after irradiation compared to the non-irradiated marrow (P Ͻ 0.05).
endothelial permeability to macromolecules, such as the macromolecular contrast agent CMD-Gd-DOTA. The extravasation of small molecules, such as the small molecular contrast agent Gd-DOTA on the other hand, is not affected by changes in sinus permeability. Differences in bone marrow MR signal enhancement between the small molecular and the macromolecular contrast agent can be explained by different pharmacokinetics of these contrast agents. The tissue enhancement following the administration of small molecular, 'extracellular' contrast agents like the standard MR contrast agent gadoterate depends mainly on the arterial blood supply and the size of the extracellular volume whereas tissue enhancement following injection of macromolecular contrast agents is determined by their fractional plasma volume and microvascular permeability. 14, 21, 22 Small molecular tracers, such as gadoterate, already extravasate across the intact microvessel endothelium into virtually any extracerebral tissue and thus, are not able to determine an increase in microvascular permeability. [23] [24] [25] [26] Macromolecular blood pool contrast agents on the other hand are confined to the vascular space in normal conditions. Therefore, an increased permeability of the microvessel endothelium can be diagnosed and graded by an increased extravasation of macromolecular contrast media into the tissue interstitium with consecutive increased enhancement on the MR image. 14, 21, 22 Using macromolecular MR contrast agents, investigators have repeatedly quantified irradiation-induced capillary hyperpermeabilities in normal and neoplastic tissues. 17, 18 Because of its considerably larger molecular weight than gadoterate (approximately 100 times larger), CMD-Gd-DOTA does not easily penetrate normal sinus endothelium, but traverses hyperpermeable sinusoids following irradiation. CMD-Gd-DOTA enhanced MRI demonstrated a high specificity to characterize bone marrow microvascular integrities. The increased permeability of CMD-Gd-DOTA across the sinus endothelium following irradiation was due to irradiation-induced alterations of the bone marrow microvascular ultrastructure: ie sloughing and denudation of plasma membranes, acute cytoplasmatic swelling of endothelium and endothelial discontinuities. 2, 3 These effects of irradiation on biomembranes have been demonstrated in many other cell systems. 2, 27, 28 At a molecular level, irradiation induced structural alterations of membrane proteins, alterations of the lipid bilayer and a reduced activity of membrane-bound adenyl cyclase and ATP, which all caused an increase in membrane fluidity. 2, 29, 30 However, the radiosensitivity of biomembranes varies with the cell type and and the radiation dose.
2 Dynamic macromolecular contrast medium enhanced MRI may be used to grade these irradiation-induced permeability alterations of the marrow sinus endothelium in vivo.
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In this study, the permeability of the blood-bone marrow barrier was quantified by an exogenous, macromolecular, dextran-based tracer, which traverses the sinus endothelium by passive diffusion or vesicular transport. 20 No correlation was obtained between the endothelial permeability of this macromolecular MR contrast agent and the endothelial permeability of blood stem cells. Intravenously administered hematopoietic cells demonstrate not only passsive transport mechanisms but adhesive interactions with the bone marrow stroma and active migration across the sinus endothelium. 31 However, recent investigations demonstrated that donor hemopoietic cells are not selectively taken up by the preconditioned bone marrow, as they are distributed widely in several other tissues, and that engraftment may be rather the effect of preferential survival and proliferation than selective uptake into the host's marrow compartment. 31 In addition, histopathological studies demonstrated morphological evidence that the blood-bone marrow barrier becomes ineffective following irradiation and that subsequent cellular exchange can occur freely between vascular and hematopoietic compartments.
2 Irradiation-induced disruption and damage of the bone marrow stroma and sinus endothelium caused an enhanced BMB permissiveness, such that mature, nonreticulated erythrocytes that are normally confined to the vascular space appeared in large numbers in the hematopoietic marrow. 2 Further studies have to show if MRI measures of BMB permeability correlate with the early traffic of intravenously injected hematopoietic cells into the bone marrow compartment.
Conclusions are limited by the scope and design of this study. The immature bone marrow of the New Zealand white rabbit is a model well suited for the current study since hematopoietic marrow is found within the central skeleton and its MR appearance has been well described before. 32, 33 In addition, good anatomical resolution can be achieved for rabbits using a clinical MR scanner, which would not have been possible for smaller rodents. Our findings still have to be confirmed in humans.
Using CMD-Gd-DOTA enhanced MRI, the integrity of the blood-bone marrow barrier could be accurately defined in vivo. This technique may be potentially useful for various clinical applications, dealing with effects of conditioning regimens on bone marrow stroma and the traffic of cells or macromolecules between the vascular and extravascular hematopoietic marrow compartments. For example, CMDGd-DOTA enhanced MRI may be used to define the permeability of the blood-bone marrow barrier prior to blood stem cell mobilization or to optimize the time of donor cell infusion in bone marrow transplantation. 2 In addition, this new MRI technique may be used to monitor irradiationinduced alterations of the bone marrow stroma with lower radiation doses and with alternative conditioning regimens, based on chemotherapy alone. 34 Our findings encourage continuing investigations of MRI-derived measures of bone marrow microvascular permeability in humans and correlations with clinical outcome, that may have been influenced by the blood-bone marrow barrier, such as blood stem cell engraftment.
